Media Advisory - Canada-wide Vioxx settlement approved

LONDON, ON, April 19, 2013 /CNW/ - A settlement has been approved which 
resolves Vioxx claims across Canada. 
Class actions were filed across Canada on behalf of individuals who used 
and/or purchased Vioxx, a prescription pain medication distributed by Merck 
Frosst Canada Ltd. ("Merck"), which was available in Canada until September 
30, 2004. The lawsuits included allegations that individuals ingesting Vioxx 
were placed at an increased risk of experiencing various medical conditions 
including a heart attack (myocardial infarction), sudden cardiac death, or 
ischemic stroke and that a proper warning of these increased risks was not 
provided. 
The allegations made in the class actions have not been proven in court and 
the courts have not taken any position as to the truth or merits of the claims 
or defences asserted by either side. Merck denies the allegations and states 
that it made the results of its studies available to the scientific community 
and regulatory authorities around the world. 
The settlement is for up to $36,881,250.00 depending upon the number of claims 
ultimately approved, and includes payments to provincial health insurers, 
payments towards legal costs, and payments for notice and claims 
administration. Individuals (or their estates) may be eligible to receive 
payment if they took Vioxx and then experienced a myocardial infarction, 
sudden cardiac death or ischemic stroke while taking, or shortly after 
stopping, Vioxx. Spouses and children of eligible claimants may also be 
eligible for payment. 
Under the terms of the settlement, eligible claimants will receive payment 
based on the type of event they experienced and a number of other factors 
including duration of use of Vioxx and risk factors. 
Class Counsel is very pleased with the settlement which will result in 
significant payments being distributed to eligible claimants. According to 
Michael Peerless of Siskinds LLP, one of the lead counsel for the plaintiffs 
who negotiated the settlement, "It is an excellent result in a very 
challenging case." 
Individuals in Canada who used Vioxx are represented by a consortium of firms 
across the country. Further information for class members is available at the 
website www.vioxxnationalclassaction.com. 
Claim forms can be obtained at: www.vioxxclassactionsettlement.ca or by 
contacting the Claims Administrator, NPT Ricepoint Class Action Services, at: 
1-888-507-8759. 
Please contact Sabrina Lombardi at(519) 660-7702 
(sabrina.lombardi@siskinds.com) for English enquiries or Eric Lemay at(418) 
694-2009 for French enquiries. 
SOURCE: Siskinds LLP 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/April2013/19/c6541.html 
CO: Siskinds LLP
ST: Ontario
NI: LAW VERDICTS LAWVIEWS MED  
-0- Apr/19/2013 11:00 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.